CBFA2T3 gene expression is elevated in lung adenocarcinoma cell lines A549 and H2122, and CBFA2T3 has been identified as potential tumor antigens for mRNA vaccine development in lung adenocarcinoma [9,10]. This evidence concerns the gene CBFA2T3 and lung adenocarcinoma.